湖岸生物上涨6.79%，报0.77美元/股，总市值3171.32万美元

Core Viewpoint - Lakeshore Biosciences (LSB) experienced a stock price increase of 6.79%, reaching $0.77 per share, with a total market capitalization of $31.7132 million as of August 6 [1] Financial Performance - As of March 31, 2025, Lakeshore Biosciences reported total revenue of 615 million RMB, reflecting a year-on-year growth of 7.24% [1] - The company recorded a net profit attributable to shareholders of -99.9825 million RMB, which represents a significant year-on-year increase of 76.93% [1] Company Overview - Lakeshore Biosciences is a Cayman Islands-registered holding company primarily operated by its domestic subsidiary, Beijing Yisheng Biotechnology Co., Ltd. [1] - Beijing Yisheng Biotechnology Co., Ltd. is a global biopharmaceutical company focused on the discovery, development, production, and commercialization of next-generation vaccines and therapeutic biologics for infectious diseases and cancer [1]